SG11201401071YA - Glycosylated polypeptide and pharmaceutical composition containing same - Google Patents
Glycosylated polypeptide and pharmaceutical composition containing sameInfo
- Publication number
- SG11201401071YA SG11201401071YA SG11201401071YA SG11201401071YA SG11201401071YA SG 11201401071Y A SG11201401071Y A SG 11201401071YA SG 11201401071Y A SG11201401071Y A SG 11201401071YA SG 11201401071Y A SG11201401071Y A SG 11201401071YA SG 11201401071Y A SG11201401071Y A SG 11201401071YA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing same
- glycosylated polypeptide
- glycosylated
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011218793 | 2011-10-01 | ||
| PCT/JP2012/075262 WO2013047846A1 (ja) | 2011-10-01 | 2012-09-28 | 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401071YA true SG11201401071YA (en) | 2014-08-28 |
Family
ID=47995870
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401071YA SG11201401071YA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
| SG10201602076QA SG10201602076QA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201602076QA SG10201602076QA (en) | 2011-10-01 | 2012-09-28 | Glycosylated polypeptide and pharmaceutical composition containing same |
Country Status (16)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014CN02982A (enrdf_load_stackoverflow) | 2011-10-01 | 2015-07-03 | Glytech Inc | |
| CN104334574B (zh) * | 2013-03-29 | 2020-01-14 | 株式会社糖锁工学研究所 | 附加唾液酸化糖链的多肽 |
| CN114685645B (zh) * | 2020-12-30 | 2025-03-21 | 深圳翰宇药业股份有限公司 | 一种索玛鲁肽的合成方法 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0237019A3 (en) | 1986-03-14 | 1988-03-09 | Toray Industries, Inc. | Interferon conjugate and production thereof using recombinant gene |
| CA2278178C (en) | 1997-01-16 | 2012-09-25 | Cytel Corporation | Practical in vitro sialylation of recombinant glycoproteins |
| DE19717864C2 (de) | 1997-04-23 | 2001-05-17 | Fraunhofer Ges Forschung | Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung |
| DK1075281T3 (da) * | 1998-04-28 | 2005-01-03 | Applied Research Systems | Polyol-IFN-beta-konjugater |
| EP1121156B1 (en) | 1998-10-16 | 2006-02-22 | Biogen Idec MA Inc. | Polymer conjugates of interferon beta- 1a and their uses |
| EA005005B1 (ru) * | 1998-10-16 | 2004-10-28 | Байоджен, Инк. | ГИБРИДНЫЙ ПОЛИПЕПТИД β1α-ИНТЕРФЕРОНА ЧЕЛОВЕКА, ЕГО МУТАНТНЫЕ ФОРМЫ И ПРОИЗВОДНЫЕ И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ |
| US6514729B1 (en) | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
| EP1240327B1 (en) * | 1999-12-08 | 2008-02-06 | Amgen Inc., | Interferon-like molecules and uses thereof |
| US7795002B2 (en) * | 2000-06-28 | 2010-09-14 | Glycofi, Inc. | Production of galactosylated glycoproteins in lower eukaryotes |
| JP2004518621A (ja) | 2000-09-08 | 2004-06-24 | グリフォン セラピューティクス，インコーポレーテッド | 「擬似」天然型化学的ライゲーション |
| BR0207576A (pt) | 2001-02-27 | 2004-04-27 | Maxygen Aps | Variante glicosilada de um polipeptìdeo de interferon beta precursor (ifnb), processos de aumentar a glicosilação in vivo de uma molécula de ifnb precursora, de produzir uma molécula de ifnb glicosilada, para preparar uma variante conjugada e de tratar um mamìfero com esclerose múltiplam composição farmacêutica, molécula de ifnb variante, sequência de nucleotìdeo, vetor de expressão, célula hospedeira de glicosilação conjugado, e, uso de um conjugado |
| PL362870A1 (en) | 2001-03-15 | 2004-11-02 | Merck Patent Gmbh | Modified interferon beta with reduced immunogenicity |
| HK1080090B (zh) * | 2001-10-10 | 2012-12-14 | 诺和诺德公司 | 肽的重构和糖缀合的方法 |
| US7226903B2 (en) * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
| WO2003054006A2 (en) | 2001-12-11 | 2003-07-03 | Aventis Pasteur | Mutated hiv tat |
| US20060083715A1 (en) * | 2002-03-12 | 2006-04-20 | Steven Glazer | Interferon beta-like molecules for treatment of stroke |
| US7943763B2 (en) | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| WO2004020468A2 (en) | 2002-08-28 | 2004-03-11 | Maxygen Aps | Interferon beta-like molecules for treatment of cancer |
| NZ565990A (en) * | 2002-09-27 | 2009-10-30 | Biogen Idec Inc | Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| EP1581631A4 (en) | 2002-10-01 | 2007-09-05 | Xencor Inc | INTERFERON VARIANTS HAVING IMPROVED PROPERTIES |
| US20060166929A1 (en) | 2002-12-26 | 2006-07-27 | Yasuhiro Kajihara | Sugar-chain asparagine derivatives and processes for the preparation thereof |
| EP1666496B1 (en) | 2003-08-25 | 2014-03-12 | Toray Industries, Inc. | Interferon-beta composite |
| EP1734988A4 (en) | 2004-03-01 | 2009-08-05 | Enzon Pharmaceuticals Inc | INTERFERON BETA-polymer |
| RU2392963C2 (ru) * | 2004-08-09 | 2010-06-27 | Элиоз Байофарма, Инк. | Синтетические варианты гипергликозилированного протеазо-резистентного полипептида, пероральные композиции и способы применения таких вариантов |
| EP1789074A4 (en) | 2004-08-09 | 2009-08-12 | Alios Biopharma Inc | PROTEASE-RESISTANT HYPERGLYCOSYL SYNTHETIC POLYPEPTIDE VARIANTS, ORAL FORMULATIONS AND METHODS OF USING THE SAME |
| KR100781666B1 (ko) * | 2004-11-02 | 2007-12-03 | 신영기 | 인간 인터페론-베타 변이체 |
| JP4944112B2 (ja) * | 2005-08-26 | 2012-05-30 | アレス トレーディング ソシエテ アノニム | グリコシル化されたインターフェロンベータの調製方法 |
| US20080003202A1 (en) * | 2006-03-28 | 2008-01-03 | Thierry Guyon | Modified interferon-beta (IFN-beta) polypeptides |
| US20080096819A1 (en) | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| TWI423821B (zh) | 2007-06-19 | 2014-01-21 | Glucose-containing glucagon-like peptide-1 peptide | |
| RU2478105C2 (ru) | 2007-07-31 | 2013-03-27 | Глитек, Инк. | Способ получения пептида |
| JP2009242372A (ja) | 2008-03-11 | 2009-10-22 | Yokohama City Univ | 均一な糖鎖構造を有するエリスロポエチン誘導体 |
| KR101609005B1 (ko) | 2008-06-17 | 2016-04-04 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 당쇄 부가 ｇｌｐ－１ 펩티드 |
| WO2010015722A1 (en) | 2008-08-08 | 2010-02-11 | Vib Vzw | Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof |
| AU2009283678B2 (en) * | 2008-08-19 | 2014-01-16 | Glytech, Inc. | Glycoprotein production method and screening method |
| WO2012051615A1 (en) | 2010-10-15 | 2012-04-19 | Transgenrx, Inc. | Novel vectors for production of glycosylated interferon |
| KR101920947B1 (ko) | 2011-03-10 | 2018-11-21 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 시알릴 당쇄를 갖는 당펩티드의 제조방법, 당해 제조방법에 사용하는 시알릴 당쇄 부가 아미노산 유도체 및 당해 당펩티드 |
| US9487566B2 (en) | 2011-06-29 | 2016-11-08 | Kyowa Hakko Kirin Co., Ltd | Method for purifying protein |
| IN2014CN02982A (enrdf_load_stackoverflow) | 2011-10-01 | 2015-07-03 | Glytech Inc |
-
2012
- 2012-09-28 IN IN2982CHN2014 patent/IN2014CN02982A/en unknown
- 2012-09-28 JP JP2013536471A patent/JP6153470B2/ja not_active Expired - Fee Related
- 2012-09-28 CN CN201280058952.8A patent/CN104080803B/zh active Active
- 2012-09-28 CA CA2850469A patent/CA2850469C/en active Active
- 2012-09-28 KR KR1020147010631A patent/KR101979045B1/ko not_active Expired - Fee Related
- 2012-09-28 PH PH1/2014/500694A patent/PH12014500694B1/en unknown
- 2012-09-28 SG SG11201401071YA patent/SG11201401071YA/en unknown
- 2012-09-28 DK DK12836998.0T patent/DK2762489T3/en active
- 2012-09-28 US US14/347,222 patent/US10358470B2/en active Active
- 2012-09-28 MY MYPI2014000925A patent/MY168902A/en unknown
- 2012-09-28 CN CN201811042210.1A patent/CN109134642A/zh active Pending
- 2012-09-28 AU AU2012317325A patent/AU2012317325B2/en not_active Ceased
- 2012-09-28 RU RU2014116550A patent/RU2636456C2/ru active
- 2012-09-28 EP EP12836998.0A patent/EP2762489B1/en active Active
- 2012-09-28 WO PCT/JP2012/075262 patent/WO2013047846A1/ja active Application Filing
- 2012-09-28 BR BR112014007766-5A patent/BR112014007766B1/pt not_active IP Right Cessation
- 2012-09-28 SG SG10201602076QA patent/SG10201602076QA/en unknown
- 2012-10-01 TW TW101136177A patent/TWI633115B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR112014007766B1 (pt) | 2022-05-10 |
| JP6153470B2 (ja) | 2017-06-28 |
| TWI633115B (zh) | 2018-08-21 |
| EP2762489B1 (en) | 2018-03-28 |
| WO2013047846A1 (ja) | 2013-04-04 |
| IN2014CN02982A (enrdf_load_stackoverflow) | 2015-07-03 |
| RU2636456C2 (ru) | 2017-11-23 |
| TW201321404A (zh) | 2013-06-01 |
| MY168902A (en) | 2018-12-04 |
| AU2012317325B2 (en) | 2016-10-06 |
| PH12014500694B1 (en) | 2020-01-31 |
| DK2762489T3 (en) | 2018-07-02 |
| JPWO2013047846A1 (ja) | 2015-03-30 |
| AU2012317325A1 (en) | 2014-04-17 |
| BR112014007766A2 (pt) | 2017-04-04 |
| CA2850469C (en) | 2020-07-07 |
| CA2850469A1 (en) | 2013-04-04 |
| US20140369964A1 (en) | 2014-12-18 |
| PH12014500694A1 (en) | 2014-05-12 |
| EP2762489A9 (en) | 2015-02-11 |
| KR20140095051A (ko) | 2014-07-31 |
| RU2014116550A (ru) | 2015-10-27 |
| CN109134642A (zh) | 2019-01-04 |
| KR101979045B1 (ko) | 2019-05-15 |
| CN104080803B (zh) | 2020-08-04 |
| CN104080803A (zh) | 2014-10-01 |
| EP2762489A1 (en) | 2014-08-06 |
| SG10201602076QA (en) | 2016-04-28 |
| US10358470B2 (en) | 2019-07-23 |
| EP2762489A4 (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262667B (en) | An isolated polynucleotide encoding a polypeptide and a pharmaceutical composition containing the isolated polynucleotide | |
| SG11201400293UA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
| IL253870B (en) | Certain amino-pyrimidines and pharmaceutical preparations containing them | |
| ZA201305504B (en) | Compositions containing glycosylated antibodies and uses thereof | |
| IL245328B (en) | A pharmaceutical preparation containing carbatocin | |
| IL243264B (en) | Stabilizing agent for pharmaceutical proteins | |
| EP2699590B8 (en) | Endoglin polypeptides and uses thereof | |
| ZA201400762B (en) | Relaxin fusion polypeptides and uses thereof | |
| IL230918A0 (en) | Modified proteins and peptides | |
| IL230463A0 (en) | Benzamides, their preparation and pharmaceutical preparations containing them | |
| SG11201405578TA (en) | Pharmaceutical composition containing peptide | |
| ZA201302113B (en) | Caspofungin composition | |
| SG11201402139UA (en) | High mast2-affinity polypeptides and uses thereof | |
| ZA201207375B (en) | Stabilized pharmaceutical composition | |
| ZA201400340B (en) | Pharmaceutical composition comprising ebastine and fluticasone | |
| SG11201401071YA (en) | Glycosylated polypeptide and pharmaceutical composition containing same | |
| IL221501A (en) | Medicinal product containing miramistine | |
| SG11201400289SA (en) | Glycosylated polypeptide and drug composition containing said polypeptide | |
| EP2743252A4 (en) | TETRAVALENT PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
| PL2918267T3 (pl) | Kompozycja farmaceutyczna w postaci cząstek stałych | |
| EP2751129A4 (en) | PROTEIN P14 WITH CANCER, ANTIALLERGIC EFFECT AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| ZA201309537B (en) | Pharmaceutical composition comprising fexofedine | |
| GB201121236D0 (en) | Proteins and peptides | |
| GB201121226D0 (en) | Modified proteins and peptides | |
| GB201121233D0 (en) | Modified proteins and peptides |